Buy Ranbaxy Laboratories, target of Rs 500: Angel

39751 Investors following Ranbaxy Labs. Share this News with them.

0

Like this story, share it with millions of investors on M3

Buy Ranbaxy Laboratories, target of Rs 500: Angel

Angel Broking has maintained its buy rating on Ranbaxy Laboratories with a target of Rs 500. The research firm remains positive on Ranbaxy in the long term.

Post your opinion here

 

0

Tweet

Share on Tumblr

RELATED NEWS Dishman Pharma an outperformer: Karvy ACC a market performer: HDFC Securities Add Hero Honda, target of Rs 920: IIFL Buy Idea Cellular, target of Rs 112: IIFL Jindal Saw has target of Rs 987: HDFC Securities ALSO READ See previous views by Angel Broking See what other Experts & Brokerages are saying about Ranbaxy Labs See messages about Ranbaxy Labs Ranbaxy Labs BSE | NSE 28/05/12 Are Mutual Funds betting on Ranbaxy Labs?

Angel Broking has maintained its buy rating on Ranbaxy Laboratories with a target of Rs 500 in its September 18, 2008 research report. "we remain positive on Ranbaxy in the long term and maintain a Buy on the stock with a SOTP Target Price of Rs 500, wherein the core business fetches Rs 365 and Rs 135 would account for the FTF opportunities and cash lying on the Balance Sheet," says Angel Brokings' research report.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

To read the full report click on the attachment......